Livaux® gold kiwifruit powder - the world's most awarded prebiotic
Livaux® has won multiple NutraIngredients "Prebiotic of the Year" awards across the USA, Europe, and Asia. Produced in New Zealand from non-GMO gold kiwifruit using a gentle freeze-dry process, it delivers the fruit's full natural bioactive matrix - complex fibre, pectin, polyphenols, and vitamins C and E.
Two human clinical studies have demonstrated that Livaux® significantly increases F. prausnitzii abundance - in one trial approximately doubling F. prau relative abundance, with participants also reporting improvements in digestive comfort and quality of life. A 600mg per day study found Livaux® raised F. prau numbers, improved laxation, reduced bloating and abdominal discomfort, and decreased gas-producing bacteria while increasing beneficial bacteria. Livaux® contains 41 unique bioactive phenolic compounds across 27 classes - over 355% more phenolic diversity than inulin.
OxiFend green kiwifruit enzyme extract - actinidin and digestive support
This freeze-dried NZ-grown green kiwifruit extract delivers high-potency actinidin enzyme activity - a cysteine protease (EC 3.4.22.14) that is highly active at stomach acid pH (1.5–3.5), unlike common digestive enzymes such as bromelain and papain which require a much higher pH to function. This makes actinidin uniquely effective at supporting protein digestion right where it begins - in the stomach.
Research has shown that actinidin from kiwifruit significantly increases the rate of digestion of dairy, meat, and soy proteins. OxiFend also contributes soluble fibre and polyphenols that support the growth of beneficial gut bacteria, including Lactobacillus acidophilus and Bifidobacterium bifidum.
What are the benefits of F. prausnitzii?
F. prau is one of the most important beneficial bacteria in the human gut. It has anti-inflammatory actions, supports immune function, and is a major producer of butyrate - a short-chain fatty acid that fuels the cells lining the colon and plays a central role in gut and systemic health. Low levels of F. prau have been associated with inflammatory bowel disease, IBS, obesity, type 2 diabetes, and certain neurological conditions. Supporting F. prau through targeted prebiotic nutrition is one of the most evidence-backed approaches to improving gut health.